You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

T-lymphocyte

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hepatocellular Carcinoma Trial in Yichang (Sintilimab)

Recruiting
  • Hepatocellular Carcinoma
  • Yichang, Hubei, China
    Department of Medical Oncology, Central Hospital of Yichang City
Sep 1, 2023

MDR-TB, Immunotherapy Trial in Shanghai (V?2Vd2 T lymphocyte-based immunotherapy, Treatment regimens for MDR-TB)

Recruiting
  • MDR-TB
  • Immunotherapy
  • Vγ2Vδ2 T lymphocyte-based immunotherapy
  • Treatment regimens for MDR-TB
  • Shanghai, China
  • +1 more
Aug 8, 2022

COL6A3 Positive, HLA-A*0201 Positive Cells Present, PRAME Positive Trial in Houston (biological, drug, procedure)

Active, not recruiting
  • COL6A3 Positive
  • +3 more
  • Aldesleukin
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 22, 2022

T Cell Lymphoma, T-cell Leukemia Trial in Beijing (Efficacy of LCAR-T2C CAR-T cells)

Terminated
  • T Cell Lymphoma
  • T-cell Leukemia
  • Efficacy of LCAR-T2C CAR-T cells
  • Beijing, Beijing, China
  • +1 more
Aug 12, 2022

Healthy Volunteers Trial in Paris (Collection of mobilized hematopoietic stem cells (apheresis products) from healthy

Recruiting
  • Healthy Volunteers
  • Collection of mobilized hematopoietic stem cells (apheresis products) from healthy volunteers
  • Paris, France
    CIC Paris Est, Hôpital Pitié Salpêtrière
Jun 8, 2022

GVHD Trial in Ramat Gan (Cyclophosphamide, anti-human T-lymphocyte immunoglobulin (ATLG))

Recruiting
  • Graft Versus Host Disease
  • Ramat Gan, Israel
    Chaim Sheba Medical Center
May 4, 2022

Hematopoietic Organs; Disorder Trial in Hong Kong (CD62L depleted donor lymphocyte infusion)

Recruiting
  • Hematopoietic Organs; Disorder
  • CD62L depleted donor lymphocyte infusion
  • Hong Kong, Hong Kong
    Hong Kong Children's Hospital
Sep 6, 2023

CTLA4 Haploinsufficency, Chronic Cytopenia Trial run by the National Institute of Allergy and Infectious Diseases (NIAID)

Recruiting
  • CTLA4 Haploinsufficency
  • Chronic Cytopenia
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 24, 2022

Glioblastoma, Malignant Glioma, Recurrent Glioblastoma Trial in Boston (CARv3-TEAM-E T cells)

Not yet recruiting
  • Glioblastoma
  • +3 more
  • CARv3-TEAM-E T cells
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
Dec 13, 2022

Recurrent Glioblastoma Trial (Targeted Epidermal Growth Factor Receptor Variant III(EGFRvIII) autochimeric antigen receptor T

Not yet recruiting
  • Recurrent Glioblastoma
  • Targeted Epidermal Growth Factor Receptor Variant III(EGFRvIII) autochimeric antigen receptor T cell injection
  • (no location specified)
Apr 4, 2023

De Novo Kidney Transplant Patients Trial in China (ATG-F)

Completed
  • De Novo Kidney Transplant Patients
  • Beijing, China
  • +13 more
Jul 26, 2022

Multiple Myeloma, Allogeneic Stem Cell Transplantation Trial in Spain (CARTemis-1)

Not yet recruiting
  • Multiple Myeloma
  • Allogeneic Stem Cell Transplantation
  • CARTemis-1
  • Santander, Cantabria, Spain
  • +4 more
Aug 1, 2023

Late Toxicities After Radiotherapy in Breast and Prostate Cancer

Completed
  • Breast Cancer
  • Prostate Cancer
    • Montpellier, France
      CRLC Val d'Aurelle
    Nov 29, 2022

    Myeloid Diseases Trial in Middletown, New York (drug, radiation, procedure)

    Recruiting
    • Myeloid Diseases
    • Antithymocyte globulin (Rabbit)
    • +5 more
    • Middletown, New Jersey
    • +1 more
    Jan 19, 2023

    Moderate COVID-19-infection Trial in Cologne (human SARS-CoV 2 specific T lymphocytes)

    Terminated
    • Moderate COVID-19-infection
    • human SARS-CoV 2 specific T lymphocytes
    • Cologne, NRW, Germany
      Department I for Internal Medicine University Hospital of Cologn
    Sep 12, 2022

    Acute Lymphoid Leukemia (ALL), Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia (CML) Trial in New York (radiation, drug,

    Active, not recruiting
    • Acute Lymphoid Leukemia (ALL)
    • +5 more
    • Hyperfractionated total body irradiation
    • +9 more
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Jan 21, 2022

    Hematologic Malignancy Trial in Tuebingen,, Tuebingen (CD45RA depleted donor lymphocyte infusion (DLI))

    Recruiting
    • Hematologic Malignancy
    • CD45RA depleted donor lymphocyte infusion (DLI)
    • Tuebingen,, Germany
    • +1 more
    Jul 13, 2023

    B-cell Acute Lymphoblastic Leukemia, B-cell Non Hodgkin Lymphoma Trial in Aurora (CD19CAR-CD3Zeta-4-1BB-Expressing Autologous

    Recruiting
    • B-cell Acute Lymphoblastic Leukemia
    • B-cell Non Hodgkin Lymphoma
    • CD19CAR-CD3Zeta-4-1BB-Expressing Autologous T-Lymphocyte Cells
    • Aurora, Colorado
      Children's Hospital Colorado
    Nov 9, 2022

    T-Cell Large Granular Lymphocyte Leukemia Trial in Columbus (Ruxolitinib)

    Not yet recruiting
    • T-Cell Large Granular Lymphocyte Leukemia
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Oct 20, 2022

    Metastatic Malignant Tumor in the Liver, Metastatic Uveal Melanoma Trial in Houston (Aldesleukin, Autologous CD8+

    Active, not recruiting
    • Metastatic Malignant Neoplasm in the Liver
    • Metastatic Uveal Melanoma
    • Aldesleukin
    • +3 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 20, 2023

    Non-hodgkin Lymphoma,B Cell Trial (CD19-targeted non-viral PD1 site-specific integrated CAR-T cell injection)

    Not yet recruiting
    • Non-hodgkin Lymphoma,B Cell
    • CD19-targeted non-viral PD1 site-specific integrated CAR-T cell injection
    • (no location specified)
    Feb 14, 2023

    Lymphoid Leukemia, Acute, Myeloid Malignancy, Plasma Cell Tumor Trial in Miami (T-cell Receptor a/ß Depleted Donor Lymphocyte

    Recruiting
    • Lymphoid Leukemia, Acute
    • +2 more
    • T-cell Receptor α/β Depleted Donor Lymphocyte Infusions
    • Miami, Florida
      Miami Cancer Institute at Baptist Health, Inc
    May 24, 2022

    Pleural Biphasic Mesothelioma, Pleural Sarcomatoid Mesothelioma Trial (Nivolumab, Ipilimumab, Surgical Procedure)

    Not yet recruiting
    • Pleural Biphasic Mesothelioma
    • Pleural Sarcomatoid Mesothelioma
    • Nivolumab
    • +5 more
    • (no location specified)
    Dec 9, 2022

    CD4+T Lymphocytes in Primary Nephrotic Syndrome With Infection

    Recruiting
    • Nephrotic Syndrome
    • +2 more
    • The study is an observational study without intervention
    • Zhuhai, Guangdong, China
      the fifth affiliated hospital of SUN YAT-SEN university
    Nov 20, 2022

    Gastrointestinal Stromal Tumor Trial in Los Angeles (Ipilimumab, Laboratory Biomarker Analysis, Nivolumab)

    Completed
    • Gastrointestinal Stromal Tumor
    • Ipilimumab
    • +2 more
    • Los Angeles, California
      Rachel Andes
    Aug 15, 2022